Oracle Health Sciences Delivers Oracle Argus Safety from the Cloud
Oracle Health Sciences announced the availability of Oracle Argus Safety On Demand, a cloud-based version of Oracle’s integrated global adverse events management and regulatory reporting solution.
Oracle Argus Safety On Demand provides an advanced and comprehensive adverse events management system that helps life sciences companies enable regulatory compliance, drive product stewardship, and integrate safety and risk management.
As a cloud application, Oracle Argus Safety On Demand enables health sciences organizations and their contract resource organization (CRO) partners to accelerate deployment, obtain on-demand scalability, reduce IT management resource requirements and gain a more predictable IT spending pattern.
Oracle Argus Safety On Demand is part of a comprehensive portfolio of Oracle Health Sciences Cloud Applications and is powered by the Oracle Health Sciences Cloud.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
